![Daniel Abdun-Nabi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Daniel Abdun-Nabi
Director/Board Member at
APTEVO THERAPEUTICS INC.
Net worth: 728 $ as of 2026-09-29
Profile
Daniel J.
Abdun-Nabi is currently Director at Emergent Product Development UK Ltd. since 2008, Director at Biohealth Innovation, Inc. since 2013, Independent Director at Aptevo Therapeutics, Inc. since 2016, and Director at Emergent BioSolutions Canada, Inc. Formerly, Mr. Abdun-Nabi was Chief Executive Officer & Director at Emergent BioSolutions, Inc. from 2018 to 2019, Independent Director at REGENXBIO, Inc. from 2016 to 2022, Secretary, SVP-Legal Affairs & General Counsel at North American Vaccine, Inc. from 1999 to 2000, and General Counsel at both BioVeris Corp.
and IGEN International, Inc. from 1999 to 2004.
Education includes undergraduate studies at the University of Massachusetts, and graduate degrees from Georgetown University Law Center and the University of San Diego School of Law.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-08-12 | 400 ( 0.02% ) | 728 $ | 2026-09-29 |
Daniel Abdun-Nabi active positions
| Companies | Position | Start |
|---|---|---|
| APTEVO THERAPEUTICS INC. | Director/Board Member | 2016-07-31 |
Biohealth Innovation, Inc.
 Biohealth Innovation, Inc. Financial ConglomeratesFinance Sources and evaluates market-relevant bioheath intellectual properties, connects the IP with funding, and assists businesses in marketing and growth | Director/Board Member | 2013-07-29 |
Emergent BioSolutions Canada, Inc.
 Emergent BioSolutions Canada, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes immune therapeutic drugs | Director/Board Member | - |
Emergent Product Development UK Ltd.
 Emergent Product Development UK Ltd. Pharmaceuticals: MajorHealth Technology Develops oral vaccines for typhoid, travelers diarrhea, hepatitis B and anthrax | Director/Board Member | 2008-06-26 |
Former positions of Daniel Abdun-Nabi
| Companies | Position | End |
|---|---|---|
| REGENXBIO INC. | Director/Board Member | 2022-06-02 |
| EMERGENT BIOSOLUTIONS INC. | Chief Executive Officer | 2019-03-31 |
IGEN International, Inc.
 IGEN International, Inc. Medical SpecialtiesHealth Technology Develops and markets biological testing systems that incorporate its proprietary electrochemiluminescence technology for used in drug discovery, diagnostic products development as well as food and environmental safety testing | General Counsel | 2004-04-30 |
BioVeris Corp.
 BioVeris Corp. BiotechnologyHealth Technology Develops and manufactures diagnostic products | General Counsel | 2004-04-30 |
North American Vaccine, Inc.
 North American Vaccine, Inc. Pharmaceuticals: OtherHealth Technology Develops and sells vaccines for the prevention of infectious diseases | General Counsel | 1999-12-31 |
Education of Daniel Abdun-Nabi
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
65
1st degree connections
12
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
North American Vaccine, Inc.
North American Vaccine, Inc. Pharmaceuticals: OtherHealth Technology Develops and sells vaccines for the prevention of infectious diseases | Health Technology |
BioVeris Corp.
BioVeris Corp. BiotechnologyHealth Technology Develops and manufactures diagnostic products | Health Technology |
REGENXBIO, Inc.
 REGENXBIO, Inc. Pharmaceuticals: MajorHealth Technology Develops gene therapy | Health Technology |
IGEN International, Inc.
IGEN International, Inc. Medical SpecialtiesHealth Technology Develops and markets biological testing systems that incorporate its proprietary electrochemiluminescence technology for used in drug discovery, diagnostic products development as well as food and environmental safety testing | Health Technology |
University of Massachusetts
 University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Emergent BioSolutions, Inc.
 Emergent BioSolutions, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
Emergent Product Development UK Ltd.
Emergent Product Development UK Ltd. Pharmaceuticals: MajorHealth Technology Develops oral vaccines for typhoid, travelers diarrhea, hepatitis B and anthrax | Health Technology |
Biohealth Innovation, Inc.
Biohealth Innovation, Inc. Financial ConglomeratesFinance Sources and evaluates market-relevant bioheath intellectual properties, connects the IP with funding, and assists businesses in marketing and growth | Finance |
Georgetown University Law Center
 Georgetown University Law Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of San Diego School of Law
 University of San Diego School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aptevo Therapeutics, Inc.
 Aptevo Therapeutics, Inc. BiotechnologyHealth Technology Provides immunology and cancer research services | Health Technology |
Emergent BioSolutions Canada, Inc.
Emergent BioSolutions Canada, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes immune therapeutic drugs | Health Technology |
- Stock Market
- Insiders
- Daniel Abdun-Nabi
